SPOTLIGHT -
New studies in major depression find VNS improves the quality of life of patients with treatment-resistant depression and two other findings.
Topline Phase 2 Data Support Efficacy, Tolerability, and Favorable Safety of Treatment for PTSD
Blue Light Blockers: A Behavior Therapy for Mania
Non-Psychiatric Medications With Potential to Worsen Symptoms in Major Depression
Blue Light, Depression, and Bipolar Disorder
Phase 3 Study Supports Efficacy, Safety of New Chemical Entity for MDD
Psilocybin Plus SSRIs for Treatment-Resistant Major Depression